BCIL licensed a polyherbal probiotic formulation called NAUROZ for treating vaginosis that was developed by Prof. G.P. Talwar to Bipha Drug Laboratories. NAUROZ combines BASANT, a polyherbal microbicide also developed by Talwar Research Foundation, with three strains of lactobacillus. Clinical trials found the combination of BASANT and lactobacillus to be 95% effective in treating vaginosis, improving on lactobacillus alone. Bipha aims to develop a combination product using NAUROZ to help the over 30% of women in India and the US affected by vaginosis. The technology was developed by a team led by Prof